The veterinary antimicrobial susceptibility testing market is projected to reach USD 135 million by 2026 from USD 100 million in 2021, at a CAGR of 6.1% during the forecast period. Market growth can largely be attributed to factors such as the growth in the companion animal population, growing prevalence of zoonotic diseases, rising demand for animal-derived food products, rising demand for pet insurance, growing animal health expenditure, and the increasing use of antibiotics in animals. The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players. However, the high cost of veterinary antimicrobial susceptibility testing and increasing pet care costs are expected to restrain the growth of the market to a certain extent. Limited guidelines for interpreting veterinary antimicrobial test results also pose a challenge for the leading players operating in the market.
Thermo Fisher Scientific Inc. (US) held the leading position in the global veterinary antimicrobial susceptibility testing market in 2020. The company’s leading position can be attributed to its strong brand name and its wide range of products. The company has a diversified product portfolio of veterinary antimicrobial susceptibility testing systems. The Sensititre AST System is one of the company’s flagship products. This system is offered by the company’s Specialty Diagnostics segment, one of the company’s largest revenue-generating segments. The company’s strong global presence also contributes to its leading position in the market.
To know about the assumptions considered for the study download the pdf brochure
BioMérieux S.A. (France) was the second-largest player in the global veterinary antimicrobial susceptibility testing market in 2020. The company has maintained its leadership position in the market through its strong distribution networks across North America, Europe, and Asia Pacific (especially Japan and China). VITEK is one of the main veterinary AST products offered by the company. This product’s popularity has resulted in sustained growth in the company’s Clinical and Industrial segments compared to the rest of the segments. The company strategically focuses on developing new technologies and is also a part of a stewardship program. With this program, the company will equip one clinical reference laboratory and one veterinary reference laboratory with the VITEK MS and VITEK 2 systems for pathogen identification and susceptibility testing and the MYLA software for data processing. Such initiatives will increase the company’s presence in emerging markets.
Becton, Dickinson and Company (US) was the third-largest player in the global veterinary antimicrobial susceptibility testing market in 2020. To maintain its position in the market, the company focuses on the strategies of R&D and collaborations. The company’s broad portfolio of veterinary AST products also makes it a market leader. The company mainly operates in more than 190 countries. It also focuses on developing technologically advanced diagnostic products for susceptibility testing to strengthen its position in this market. The company also funds various associations and projects related to antimicrobial resistance, strengthening its presence in the veterinary antimicrobial susceptibility testing market.
Veterinary Antimicrobial Susceptibility Testing Market by Product (Disks, Plates, Media, Accessories, Consumables, Automated AST), Animal (Dog, Cat, Horse, Cattle, Pig, Poultry),End User (Veterinary Reference Labs, Universities) - Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE